Correlation Between Recursion Pharmaceuticals and Icad

Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Icad at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Icad into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Recursion Pharmaceuticals and icad inc, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Icad and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Icad. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Icad.

Diversification Opportunities for Recursion Pharmaceuticals and Icad

0.56

Correlation Coefficient

Recursion Pharmaceuticals  Icad

Very weak diversification

The 3 months correlation between Recursion and Icad is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and icad inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on icad inc and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Icad. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of icad inc has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Icad go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and Icad

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 1.02 times more return on investment than Icad. However, Recursion Pharmaceuticals is 1.02 times more volatile than icad inc. It trades about 0.05 of its potential returns per unit of risk. icad inc is currently generating about 0.03 per unit of risk. If you would invest  655.00  in Recursion Pharmaceuticals on September 17, 2024 and sell it today you would earn a total of  40.00  from holding Recursion Pharmaceuticals or generate 6.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Recursion Pharmaceuticals  vs.  icad inc

Recursion Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

icad inc

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in icad inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Icad exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Recursion Pharmaceuticals and Icad

The main advantage of trading using opposite Recursion Pharmaceuticals and Icad positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Icad can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icad will offset losses from the drop in Icad's long position.

The idea behind Recursion Pharmaceuticals and icad inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.